Liu Hanjie, Yu Lebao, Wang Bo, Liu Pi'nan, Liu Song, Li Dezhi
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, P. R. China.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 Oct 15;38(10):1186-1192. doi: 10.7507/1002-1892.202407007.
To explore the clinical features, surgical treatment, and effectiveness of neurofibromas associated with neurofibromatosis type 1 (NF1).
A clinical data of 41 patients with NF1 admitted between December 2018 and April 2024 was retrospectively analyzed. There were 15 males and 26 females, with an average age of 27.5 years (range, 5-61 years). Only one type of neurofibroma existed in 3 patients and the rest of the patients had more than two types of neurofibromas. Fourteen patients had total resection of multiple cutaneous neurofibromas (CNF). Eighteen patients of diffuse neurofibromas underwent total, near-total, or subtotal resection. Among the 13 patients of localized nodular neurofibromas, 9 of benign tumors underwent total sub-capsular resection and 4 of malignant peripheral nerve sheath tumor (MPNST) underwent maginal resection, and only 1 underwent postoperative radiotherapy and chemotherapy. Among the 15 patients of plexiform neurofibromas (PNF), 5 patients underwent both superficial and deep PNF resection, 2 underwent the superficial PNF resection, and 8 underwent the large nodular lesions in the deep PNF resection. There were 8 MPNST, of which 7 cases underwent total sub-capsular resection and large tumor capsule resection under neurophysiological monitoring, and 1 case with the tumor located on the top of the head underwent wide resection and skin grafting. One patient underwent proton knife therapy after surgery, 2 patients did not receive radiotherapy, and the remaining patients received conventional radiotherapy.
All patients were followed up after surgery, and the follow-up time was 3-66 months, with an average of 25.0 months. Patients with CNF recovered satisfactorily after surgery, and there was no recurrence during follow-up. Patients with diffuse neurofibromas relieved preoperative symptoms after surgery. Three patients with diffuse neurofibromas located in the head and face recurred during follow-up. The patients with benign localized nodular neurofibromas recovered well after surgery, and only 1 patient had transient regional neuralgia after surgery. Among the patients with MPNST, 2 patients died of recurrence and lung metastasis, while the remaining 2 patients had no recurrence and metastasis during follow-up. All preoperative symptoms disappeared in patients with benign PNF, and no tumor recurrence was observed during follow-up. Two patients with PNF located in the brachial plexus had difficulty in shoulder abduction after surgery, 1 patient with PNF located in vagus developed hoarseness after surgery. Among the 8 patients with MPNST in PNF, 1 died of lung metastases and 1 died of systemic failure. The remaining 6 patients were in stable condition during follow-up, and no tumor recurrence or metastasis was observed.
According to the clinical features of neurofibromas in patients with NF1, choosing appropriate surgical approaches can obtain good effectiveness. Because of the difficulty of completely resection, diffuse neurofibromas, especially those located in the head and face, are prone to recurrence after surgery. MPNST has the worst prognosis, high incidence of recurrence/metastasis, and short survival period. Total resection combined with radiotherapy can decrease local recurrence.
探讨1型神经纤维瘤病(NF1)相关神经纤维瘤的临床特征、手术治疗方法及疗效。
回顾性分析2018年12月至2024年4月收治的41例NF1患者的临床资料。其中男性15例,女性26例,平均年龄27.5岁(5 - 61岁)。3例患者仅有一种类型的神经纤维瘤,其余患者有两种以上类型的神经纤维瘤。14例患者接受了多发性皮肤神经纤维瘤(CNF)全切术。18例弥漫性神经纤维瘤患者接受了全切、次全切或部分切除术。13例局限性结节性神经纤维瘤患者中,9例良性肿瘤行包膜下全切术,4例恶性外周神经鞘瘤(MPNST)行边缘切除术,仅1例术后接受放疗和化疗。15例丛状神经纤维瘤(PNF)患者中,5例患者接受了深浅部PNF切除术,2例接受了浅部PNF切除术,8例接受了深部PNF的大结节性病变切除术。有8例MPNST,其中7例在神经电生理监测下行包膜下全切和大肿瘤包膜切除术,1例肿瘤位于头顶的患者行广泛切除术及植皮术。1例患者术后接受质子刀治疗,2例患者未接受放疗,其余患者接受常规放疗。
所有患者术后均进行随访,随访时间3 - 66个月,平均25.0个月。CNF患者术后恢复满意,随访期间无复发。弥漫性神经纤维瘤患者术后术前症状缓解。3例位于头面部的弥漫性神经纤维瘤患者在随访期间复发。良性局限性结节性神经纤维瘤患者术后恢复良好,仅1例术后出现短暂性局部神经痛。MPNST患者中,2例死于复发和肺转移,其余2例随访期间无复发和转移。良性PNF患者术前症状均消失,随访期间未观察到肿瘤复发。2例位于臂丛神经的PNF患者术后出现肩外展困难,1例位于迷走神经的PNF患者术后出现声音嘶哑。8例PNF合并MPNST患者中,1例死于肺转移,1例死于全身衰竭。其余6例患者随访期间病情稳定,未观察到肿瘤复发或转移。
根据NF1患者神经纤维瘤的临床特征,选择合适的手术方式可获得较好疗效。由于弥漫性神经纤维瘤完全切除困难,尤其是位于头面部者,术后易复发。MPNST预后最差,复发/转移率高,生存期短。全切联合放疗可降低局部复发率。